SCHEMBL4784820

SCHEMBL4784820

[NH]C(=O)c1nc2ccccc2n1Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.57
CYP2C9 P11712 2/20 0.57
CYP1A2 P05177 2/20 0.57
TNF P01375 1/20 0.56
KDM4E B2RXH2 2/20 0.56
POLB P06746 2/20 0.56
LMNA P02545 3/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
PDE6D O43924 1/20 0.55
ALDH1A1 P00352 1/20 0.55
ALDH2 P05091 1/20 0.55
ALDH3A1 P30838 1/20 0.55
L3MBTL1 Q9Y468 3/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TSPO P30536 2/20 0.54
CFTR P13569 1/20 0.54
HKDC1 Q2TB90 1/20 0.52
TSHR P16473 1/20 0.51
HTT P42858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4780057 0.88 CYP2C19 (0.60) CYP2C19CYP2C9CYP1A2TNFKDM4E
SCHEMBL4784826 0.85 CYP2C19 (0.57) CYP2C19CYP2C9CYP1A2TNFKDM4E
SCHEMBL4784069 0.81 CYP2C19 (0.60) CYP2C19CYP2C9CYP1A2TNFKDM4E
SCHEMBL3484774 0.79 TNF (0.56) CYP2C19CYP2C9CYP1A2TNFKDM4E
SCHEMBL38658934 0.78 SMN1; SMN2 (0.56) CYP2C19CYP2C9CYP1A2KDM4EPOLB
SCHEMBL7792012 0.78 L3MBTL1 (0.54) CYP2C19CYP2C9CYP1A2TNFKDM4E
SCHEMBL9427638 0.76 TNF (0.65) CYP2C19CYP2C9CYP1A2TNFKDM4E
SCHEMBL152719 0.76 TNF (0.65) CYP2C19CYP2C9CYP1A2TNFLMNA
SCHEMBL5918179 0.75 HTT (0.67) CYP2C19CYP2C9CYP1A2KDM4EPOLB
SCHEMBL4728304 0.75 CYP1A2 (0.53) CYP2C19CYP2C9CYP1A2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008033739-A2 BENZIMIDAZOLE CARBOXAMIDE DERIVATIVES NEUROGEN CORPORATION (US) 2008-03-20 WO disclosed